Back to search

Article

Sex differences in cardiomyocyte proteomic responses to the cardiotoxic chemotherapy drug doxorubicin

2026-04-24

Abstract excerpt

Anthracyclines, including doxorubicin, are widely used chemotherapeutic agents, but dose-dependent cardiotoxicity limits their clinical utility and increases the risk of heart failure in cancer survivors. In paediatric patients, female sex is a significant risk factor for anthracycline-associated cardiotoxicity, yet pre-clinical studies rarely investigate sex differences in immature hearts. Here, we provide a prot...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
e4abf998-73e4-50bf-a4f9-b76e3605b55b
DOI
10.64898/2026.04.21.715711
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Sex differences in cardiomyocyte proteomic responses to the cardiotoxic chemotherapy drug doxorubicinDOI 10.64898/2026.04.21.715711
Select a neighboring publication to make it the new centre.